Successful use of adjuvant raloxifene treatment in clozapine-resistant schizophrenia

Indian Journal of Psychiatry

Volumn 54, Issue 4, 2012, Pages 394-

  Shivakumar, Venkataram ^a   Venkatasubramanian, Ganesan ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; CLOZAPINE; CYANOCOBALAMIN; LORAZEPAM; OLANZAPINE; QUETIAPINE; RALOXIFENE; RISPERIDONE; TRIHEXYPHENIDYL;

ACADEMIC ACHIEVEMENT; ADJUVANT THERAPY; ADOLESCENT; AGITATION; ATTENTION; ATTENTION DISTURBANCE; AUDITORY HALLUCINATION; BLOOD CLOT; CARDIOVASCULAR RISK; CASE REPORT; DELUSION; DRUG DOSE REDUCTION; FEMALE; HUMAN; LETTER; LEUKOPENIA; MENSTRUAL CYCLE; PREMENOPAUSE; RESTLESSNESS; SCHIZOPHRENIA; SIDE EFFECT; THROMBOSIS; TREATMENT RESPONSE;

EID: 84871964699     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.104848     Document Type: Letter

References (5)

1. Kulkarni J, Riedel A, de Castella AR, Fitzgerald PB, Rolfe TJ, Taffe J, et al. Estrogen-a potential treatment for schizophrenia. Schizophr Res 2001;48:137-44.
2. Yaffe K, Krueger K, Cummings SR, Blackwell T, Henderson VW, Sarkar S, et al. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: The Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry 2005;162:683-90.
3. Kulkarni J, Gurvich C, Lee SJ, Gilbert H, Gavrilidis E, de Castella A, et al. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology 2010;35:1142-7.
4. Cohen RZ, Seeman MV, Gotowiec A, Kopala L. Earlier puberty as a predictor of later onset of schizophrenia in women. Am J Psychiatry 1999;156:1059-64.
5. Hochman KM, Lewine RR. Age of menarche and schizophrenia onset in women. Schizophr Res 2004;69:183-8.